Product
SPN-538
1 clinical trial
2 indications
Indication
Migraine DisordersIndication
Headache DisordersClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of SPN-538 as a Therapy for the Prevention of Migraine in Subjects Ages 6-11 YearsStatus: Recruiting, Estimated PCD: 2024-12-31